Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM

PHASE3CompletedINTERVENTIONAL
Enrollment

2,122

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

December 31, 2010

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

linagliptine 5 mg

safety and efficacy of linagliptine 5 mg open label

DRUG

linagliptine 5 mg and pioglitazone 30 mg

efficacy and safety of the combination linagliptine and pioglitazone

Trial Locations (232)

Unknown

1218.40.10003 Boehringer Ingelheim Investigational Site, Chula Vista

1218.40.10014 Boehringer Ingelheim Investigational Site, Spring Valley

1218.40.10001 Boehringer Ingelheim Investigational Site, Walnut Creek

1218.40.10021 Boehringer Ingelheim Investigational Site, Northglenn

1218.40.10010 Boehringer Ingelheim Investigational Site, Hollywood

1218.40.10011 Boehringer Ingelheim Investigational Site, Miami

1218.40.10016 Boehringer Ingelheim Investigational Site, Eugene

1218.40.10002 Boehringer Ingelheim Investigational Site, Greer

1218.40.10004 Boehringer Ingelheim Investigational Site, Simpsonville

1218.40.10005 Boehringer Ingelheim Investigational Site, Dallas

1218.40.10018 Boehringer Ingelheim Investigational Site, Houston

1218.40.10007 Boehringer Ingelheim Investigational Site, San Antonio

1218.40.10009 Boehringer Ingelheim Investigational Site, Federal Way

1218.40.54002 Boehringer Ingelheim Investigational Site, Capital Federal

1218.40.54010 Boehringer Ingelheim Investigational Site, Capital Federal

1218.40.54011 Boehringer Ingelheim Investigational Site, Mendoza

1218.40.54015 Boehringer Ingelheim Investigational Site, Parque Velez Sarfield

1218.40.43001 Boehringer Ingelheim Investigational Site, Graz

1218.40.43005 Boehringer Ingelheim Investigational Site, Vienna

1218.40.32005 Boehringer Ingelheim Investigational Site, Bruges

1218.40.32007 Boehringer Ingelheim Investigational Site, Brussels

1218.40.32006 Boehringer Ingelheim Investigational Site, Edegem

1218.40.32004 Boehringer Ingelheim Investigational Site, Genk

1218.40.32003 Boehringer Ingelheim Investigational Site, Ghent

1218.40.32002 Boehringer Ingelheim Investigational Site, Huy

1218.40.32001 Boehringer Ingelheim Investigational Site, Liège

1218.40.01005 Boehringer Ingelheim Investigational Site, Calgary

1218.40.01010 Boehringer Ingelheim Investigational Site, Calgary

1218.40.01003 Boehringer Ingelheim Investigational Site, Vancouver

1218.40.01011 Boehringer Ingelheim Investigational Site, Vancouver

1218.40.01006 Boehringer Ingelheim Investigational Site, Etobicoke

1218.40.01009 Boehringer Ingelheim Investigational Site, Hamilton

1218.40.01002 Boehringer Ingelheim Investigational Site, London

1218.40.01012 Boehringer Ingelheim Investigational Site, Oakville

1218.40.01008 Boehringer Ingelheim Investigational Site, Sarnia

1218.40.20005 Boehringer Ingelheim Investigational Site, Strathroy

1218.40.01001 Boehringer Ingelheim Investigational Site, Toronto

1218.40.01004 Boehringer Ingelheim Investigational Site, Montague

1218.40.01007 Boehringer Ingelheim Investigational Site, Saskatoon

1218.40.86001 Boehringer Ingelheim Investigational Site, Beijing

1218.40.86002 Boehringer Ingelheim Investigational Site, Beijing

1218.40.86004 Boehringer Ingelheim Investigational Site, Beijing

1218.40.86013 Boehringer Ingelheim Investigational Site, Chengdu

1218.40.86009 Boehringer Ingelheim Investigational Site, Dalian

1218.40.86011 Boehringer Ingelheim Investigational Site, Guangzhou

1218.40.86014 Boehringer Ingelheim Investigational Site, Haerbin

1218.40.86008 Boehringer Ingelheim Investigational Site, Qingdao

1218.40.86015 Boehringer Ingelheim Investigational Site, Shanghai

1218.40.86010 Boehringer Ingelheim Investigational Site, Shenyang

1218.40.86007 Boehringer Ingelheim Investigational Site, Wuhan

1218.40.86012 Boehringer Ingelheim Investigational Site, Wuhan

1218.40.86006 Boehringer Ingelheim Investigational Site, Xi'an

1218.40.38605 Boehringer Ingelheim Investigational Site, Krapinske Toplice

1218.40.38604 Boehringer Ingelheim Investigational Site, Slavonski Brod

1218.40.42004 Boehringer Ingelheim Investigational Site, Brno

1218.40.42007 Boehringer Ingelheim Investigational Site, Brno

1218.40.42009 Boehringer Ingelheim Investigational Site, Brno

1218.40.42006 Boehringer Ingelheim Investigational Site, Břeclav

1218.40.42008 Boehringer Ingelheim Investigational Site, Hodonín

1218.40.42003 Boehringer Ingelheim Investigational Site, Olomouc

1218.40.35806 Boehringer Ingelheim Investigational Site, Helsinki

1218.40.35801 Boehringer Ingelheim Investigational Site, Kuopio

1218.40.35803 Boehringer Ingelheim Investigational Site, Oulu

1218.40.35805 Boehringer Ingelheim Investigational Site, Seinäjoki

1218.40.35802 Boehringer Ingelheim Investigational Site, Turku

1218.40.49028 Boehringer Ingelheim Investigational Site, Bad Mergentheim

1218.40.49022 Boehringer Ingelheim Investigational Site, Berlin

1218.40.49024 Boehringer Ingelheim Investigational Site, Bosenheim

1218.40.49020 Boehringer Ingelheim Investigational Site, Dresden

1218.40.49101 Boehringer Ingelheim Investigational Site, Mainz

1218.40.49003 Boehringer Ingelheim Investigational Site, Neuwied

1218.40.49007 Boehringer Ingelheim Investigational Site, Nuremberg

1218.40.49014 Boehringer Ingelheim Investigational Site, Saarbrücken

1218.40.30004 Boehringer Ingelheim Investigational Site, Athens

1218.40.30007 Boehringer Ingelheim Investigational Site, Athens

1218.40.30013 Boehringer Ingelheim Investigational Site, Athens

1218.40.30003 Boehringer Ingelheim Investigational Site, Nikaia

1218.40.30011 Boehringer Ingelheim Investigational Site, Piraeus

1218.40.30006 Boehringer Ingelheim Investigational Site, Thessaloniki

1218.40.30016 Boehringer Ingelheim Investigational Site, Thessaloniki

1218.40.36003 Boehringer Ingelheim Investigational Site, Budapest

1218.40.36004 Boehringer Ingelheim Investigational Site, Budapest

1218.40.36006 Boehringer Ingelheim Investigational Site, Budapest

1218.40.36008 Boehringer Ingelheim Investigational Site, Debrecen

1218.40.36005 Boehringer Ingelheim Investigational Site, Győr

1218.40.36002 Boehringer Ingelheim Investigational Site, Szombathely

1218.40.91010 Boehringer Ingelheim Investigational Site, Andhra Pradesh

1218.40.91002 Boehringer Ingelheim Investigational Site, Bangalore

1218.40.91005 Boehringer Ingelheim Investigational Site, Bangalore

1218.40.91012 Boehringer Ingelheim Investigational Site, Chennai

1218.40.91014 Boehringer Ingelheim Investigational Site, Chennai

1218.40.91009 Boehringer Ingelheim Investigational Site, Hyderabad, Andra Pradesh

1218.40.91006 Boehringer Ingelheim Investigational Site, Jaipur

1218.40.91001 Boehringer Ingelheim Investigational Site, Kerala

1218.40.91011 Boehringer Ingelheim Investigational Site, Maharashtra

1218.40.91008 Boehringer Ingelheim Investigational Site, Mangalore

1218.40.91007 Boehringer Ingelheim Investigational Site, Manipal

1218.40.91004 Boehringer Ingelheim Investigational Site, Mumbai

1218.40.91003 Boehringer Ingelheim Investigational Site, Nashik

1218.40.91013 Boehringer Ingelheim Investigational Site, Uttar Pradesh

1218.40.97274 Boehringer Ingelheim Investigational Site, Afula

1218.40.97273 Boehringer Ingelheim Investigational Site, Haifa

1218.40.97275 Boehringer Ingelheim Investigational Site, Holon

1218.40.97271 Boehringer Ingelheim Investigational Site, Jerusalem

1218.40.97272 Boehringer Ingelheim Investigational Site, Nahariya

1218.40.97276 Boehringer Ingelheim Investigational Site, Safed

1218.40.97278 Boehringer Ingelheim Investigational Site, Tel Aviv

1218.40.39008 Boehringer Ingelheim Investigational Site, Genova

1218.40.39002 Boehringer Ingelheim Investigational Site, Milan

1218.40.39001 Boehringer Ingelheim Investigational Site, Pisa

1218.40.39006 Boehringer Ingelheim Investigational Site, Roma

1218.40.81001 Boehringer Ingelheim Investigational Site, Amagasaki, Hyogo

1218.40.81005 Boehringer Ingelheim Investigational Site, Koganei, Tokyo

1218.40.81002 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1218.40.81004 Boehringer Ingelheim Investigational Site, Shinjyuku-ku,Tokyo

1218.40.81003 Boehringer Ingelheim Investigational Site, Suita, Osaka,

1218.40.60007 Boehringer Ingelheim Investigational Site, George Town

1218.40.60003 Boehringer Ingelheim Investigational Site, Kelantan

1218.40.60001 Boehringer Ingelheim Investigational Site, Kuala Lumpur

1218.40.60002 Boehringer Ingelheim Investigational Site, Kuala Lumpur

1218.40.60004 Boehringer Ingelheim Investigational Site, Perak

1218.40.60005 Boehringer Ingelheim Investigational Site, Perak

1218.40.52007 Boehringer Ingelheim Investigational Site, Aguascalientes, Ags.

1218.40.52010 Boehringer Ingelheim Investigational Site, Col.Americana, Guadalajara, Jalisco

1218.40.52008 Boehringer Ingelheim Investigational Site, Colonia Tlalpan, Mexico

1218.40.52006 Boehringer Ingelheim Investigational Site, Faccionamiento Lomas de Campestre,AGUASCAL

1218.40.52009 Boehringer Ingelheim Investigational Site, León

1218.40.52002 Boehringer Ingelheim Investigational Site, México

1218.40.52004 Boehringer Ingelheim Investigational Site, México

1218.40.52005 Boehringer Ingelheim Investigational Site, México

1218.40.52003 Boehringer Ingelheim Investigational Site, Monterrey

1218.40.52001 Boehringer Ingelheim Investigational Site, Monterrey N.L.

1218.40.31006 Boehringer Ingelheim Investigational Site, Deurne

1218.40.31001 Boehringer Ingelheim Investigational Site, Ewijk

1218.40.31010 Boehringer Ingelheim Investigational Site, Losser

1218.40.31008 Boehringer Ingelheim Investigational Site, Roelofarendsveen

1218.40.31002 Boehringer Ingelheim Investigational Site, Wildervank

1218.40.64004 Boehringer Ingelheim Investigational Site, Christchurch

1218.40.64003 Boehringer Ingelheim Investigational Site, Dunedin

1218.40.64002 Boehringer Ingelheim Investigational Site, Otahuhu

1218.40.64001 Boehringer Ingelheim Investigational Site, Tauranga

1218.40.64005 Boehringer Ingelheim Investigational Site, Wellington

1218.40.63003 Boehringer Ingelheim Investigational Site, Greenhills, San Juan

1218.40.63005 Boehringer Ingelheim Investigational Site, Manila

1218.40.63002 Boehringer Ingelheim Investigational Site, Marikina City

1218.40.63001 Boehringer Ingelheim Investigational Site, Pasig

1218.40.63004 Boehringer Ingelheim Investigational Site, Quezon City

1218.40.48603 Boehringer Ingelheim Investigational Site, Lublin

1218.40.48601 Boehringer Ingelheim Investigational Site, Warsaw

1218.40.48604 Boehringer Ingelheim Investigational Site, Zabrze

1218.40.40504 Boehringer Ingelheim Investigational Site, Alba Iulia

1218.40.40604 Boehringer Ingelheim Investigational Site, Brasov

1218.40.40501 Boehringer Ingelheim Investigational Site, Bucharest

1218.40.40502 Boehringer Ingelheim Investigational Site, Bucharest

1218.40.40603 Boehringer Ingelheim Investigational Site, Galati

1218.40.40503 Boehringer Ingelheim Investigational Site, Sibiu

1218.40.40505 Boehringer Ingelheim Investigational Site, Târgu Mureş

1218.40.70014 Boehringer Ingelheim Investigational Site, Arkhangelsk

1218.40.70001 Boehringer Ingelheim Investigational Site, Moscow

1218.40.70002 Boehringer Ingelheim Investigational Site, Moscow

1218.40.70003 Boehringer Ingelheim Investigational Site, Moscow

1218.40.70012 Boehringer Ingelheim Investigational Site, Moscow

1218.40.70005 Boehringer Ingelheim Investigational Site, Novosibirsk

1218.40.70006 Boehringer Ingelheim Investigational Site, Perm

1218.40.70013 Boehringer Ingelheim Investigational Site, Rostov-on-Don

1218.40.70015 Boehringer Ingelheim Investigational Site, Saint Petersburg

1218.40.70016 Boehringer Ingelheim Investigational Site, Samara

1218.40.70004 Boehringer Ingelheim Investigational Site, Tomsk

1218.40.42103 Boehringer Ingelheim Investigational Site, Banská Bystrica

1218.40.42102 Boehringer Ingelheim Investigational Site, Bratislava

1218.40.42104 Boehringer Ingelheim Investigational Site, Bratislava

1218.40.42105 Boehringer Ingelheim Investigational Site, Bratislava

1218.40.42101 Boehringer Ingelheim Investigational Site, Nové Mesto

1218.40.42106 Boehringer Ingelheim Investigational Site, Šamorín

1218.40.82002 Boehringer Ingelheim Investigational Site, Busan

1218.40.82011 Boehringer Ingelheim Investigational Site, Daegu

1218.40.82008 Boehringer Ingelheim Investigational Site, Incheon

1218.40.82010 Boehringer Ingelheim Investigational Site, Jeonju

1218.40.82004 Boehringer Ingelheim Investigational Site, Pusan

1218.40.82001 Boehringer Ingelheim Investigational Site, Seoul

1218.40.82005 Boehringer Ingelheim Investigational Site, Seoul

1218.40.82006 Boehringer Ingelheim Investigational Site, Seoul

1218.40.82007 Boehringer Ingelheim Investigational Site, Seoul

1218.40.82009 Boehringer Ingelheim Investigational Site, Seoul

1218.40.82003 Boehringer Ingelheim Investigational Site, Suwon

1218.40.34002 Boehringer Ingelheim Investigational Site, Badalona

1218.40.34011 Boehringer Ingelheim Investigational Site, Badia Del Vallés

1218.40.34012 Boehringer Ingelheim Investigational Site, Borges Del Camp

1218.40.34013 Boehringer Ingelheim Investigational Site, Centelles

1218.40.34007 Boehringer Ingelheim Investigational Site, Granada

1218.40.34008 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat (Barcelona)

1218.40.34009 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat (Barcelona)

1218.40.34004 Boehringer Ingelheim Investigational Site, Madrid

1218.40.34006 Boehringer Ingelheim Investigational Site, Madrid

1218.40.34010 Boehringer Ingelheim Investigational Site, Sant Adrià Del Besós (Barcelona)

1218.40.34005 Boehringer Ingelheim Investigational Site, Seville

1218.40.34014 Boehringer Ingelheim Investigational Site, Vic (Barcelona)

1218.40.46013 Boehringer Ingelheim Investigational Site, Härnösand

1218.40.46001 Boehringer Ingelheim Investigational Site, Malmo

1218.40.46012 Boehringer Ingelheim Investigational Site, Uddevalla

1218.40.46004 Boehringer Ingelheim Investigational Site, Uppsala

1218.40.88605 Boehringer Ingelheim Investigational Site, Changhua

1218.40.88604 Boehringer Ingelheim Investigational Site, Taichung

1218.40.88606 Boehringer Ingelheim Investigational Site, Tainan City

1218.40.88601 Boehringer Ingelheim Investigational Site, Taipei

1218.40.88602 Boehringer Ingelheim Investigational Site, Taipei

1218.40.88603 Boehringer Ingelheim Investigational Site, Taipei

1218.40.88607 Boehringer Ingelheim Investigational Site, Taipei

1218.40.88608 Boehringer Ingelheim Investigational Site, Taoyuan District

1218.40.66001 Boehringer Ingelheim Investigational Site, Bangkok

1218.40.66002 Boehringer Ingelheim Investigational Site, Khon Kaen

1218.40.38011 Boehringer Ingelheim Investigational Site, Dnipro

1218.40.38002 Boehringer Ingelheim Investigational Site, Kharkiv

1218.40.38004 Boehringer Ingelheim Investigational Site, Kharkiv

1218.40.38010 Boehringer Ingelheim Investigational Site, Kharkiv

1218.40.38001 Boehringer Ingelheim Investigational Site, Kiev

1218.40.38005 Boehringer Ingelheim Investigational Site, Kiev

1218.40.38008 Boehringer Ingelheim Investigational Site, Kiev

1218.40.38009 Boehringer Ingelheim Investigational Site, Kiev

1218.40.38012 Boehringer Ingelheim Investigational Site, Kiev

1218.40.38003 Boehringer Ingelheim Investigational Site, Lviv

1218.40.38006 Boehringer Ingelheim Investigational Site, Vinnitsa

1218.40.38007 Boehringer Ingelheim Investigational Site, Zaporizhzhya

1218.40.44005 Boehringer Ingelheim Investigational Site, Ashford

1218.40.44004 Boehringer Ingelheim Investigational Site, Baillieston, Glasgow

1218.40.44001 Boehringer Ingelheim Investigational Site, Bath

1218.40.44003 Boehringer Ingelheim Investigational Site, Burbage

1218.40.44010 Boehringer Ingelheim Investigational Site, Bury Saint Edmonds

1218.40.44009 Boehringer Ingelheim Investigational Site, Cardiff

1218.40.44002 Boehringer Ingelheim Investigational Site, Penarth

1218.40.44006 Boehringer Ingelheim Investigational Site, Reading

1218.40.44007 Boehringer Ingelheim Investigational Site, Waterloo, Liverpool

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00736099 - Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM | Biotech Hunter | Biotech Hunter